zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaccins - active immunisation against h5 subtype of influenza a virus.
focetria
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - vaccins contre la grippe - prophylaxie de la grippe causée par le virus a (h1n1v) 2009. focetria doit être utilisé selon les recommandations officielles.
influvac tetra susp. inj. s.c./i.m. ser. préremplie
viatris healthcare sa-nv - antigène de surface du virus influenza a-h3n2 15 µg/dose; antigène de surface du virus influenza b 15 µg/dose; antigène de surface du virus influenza b 15 µg/dose; antigène de surface du virus influenza a-h1n1 15 µg/dose - suspension injectable en seringue préremplie - virus influenza inactivé tétravalent, unités hémagglutinine et neuraminidase - influenza, inactivated, split virus or surface antigen
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - antigènes de surface du virus de la grippe (hémagglutinine et neuraminidase) de la souche a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccins - immunisation active contre le sous-type h5n1 du virus grippal a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
alpharix-tetra susp. inj. i.m. ser. préremplie
glaxosmithkline biologicals sa-nv - virus influenza a-h1n1 , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza a-h3n2 , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 15 µg ha/1 dose - suspension injectable en seringue préremplie - virus influenza inactivé tétravalent - influenza, inactivated, split virus or surface antigen
vaxigrip tetra susp. inj. s.c./i.m. ser. préremplie
sanofi pasteur europe s.a. - virus influenza a-h1n1 , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza a-h3n2 , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 15 µg ha/1 dose - suspension injectable en seringue préremplie - virus influenza inactivé tétravalent - influenza, inactivated, split virus or surface antigen
efluelda susp. inj. s.c./i.m. ser. préremplie
sanofi pasteur s.a. - virus influenza b , virion fragmenté, inactivé 60 µg ha/1 dose; virus influenza a-h1n1 , virion fragmenté, inactivé 60 µg ha/1 dose; virus influenza a-h3n2 , virion fragmenté, inactivé 60 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 60 µg ha/1 dose - suspension injectable en seringue préremplie - 60 µg ha/strain - virus influenza inactivé tétravalent - influenza, inactivated, split virus or surface antigen
influvac s susp. inj. s.c./i.m. ser. préremplie
viatris bv-srl - virus influenza inactivé trivalent - suspension injectable en seringue préremplie - virus influenza inactivé trivalent - influenza, inactivated, split virus or surface antigen
agrippal susp. inj. i.m./s.c. ser. préremplie
seqirus s.r.l. - virus influenza inactivé - suspension injectable - virus influenza inactivé - influenza, inactivated, split virus or surface antigen
fluad susp. inj. i.m. ser. préremplie
seqirus s.r.l. - virus influenza inactivé - suspension injectable - virus influenza inactivé - influenza, inactivated, split virus or surface antigen